Anti-Influenza Drug Discovery: Structure−Activity Relationship and Mechanistic Insight into Novel Angelicin Derivatives
- 21 January 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (4) , 1519-1533
Abstract
By using a cell-based high throughput screening campaign, a novel angelicin derivative 6a was identified to inhibit influenza A (H1N1) virus induced cytopathic effect in Madin−Darby canine kidney cell culture in low micromolar range. Detailed structure−activity relationship studies of 6a revealed that the angelicin scaffold is essential for activity in pharmacophore B, while meta-substituted phenyl/2-thiophene rings are optimal in pharmacophore A and C. The optimized lead 4-methyl-9-phenyl-8-(thiophene-2-carbonyl)-furo[2,3-h]chromen-2-one (8g, IC50 = 70 nM) showed 64-fold enhanced activity compared to the high throughput screening (HTS) hit 6a. Also, 8g was found effective in case of influenza A (H3N2) and influenza B virus strains similar to approved anti-influenza drug zanamivir (4). Preliminary mechanistic studies suggest that these compounds act as anti-influenza agents by inhibiting ribonucleoprotein (RNP) complex associated activity and have the potential to be developed further, which could form the basis for developing additional defense against influenza pandemics.Keywords
This publication has 26 references indexed in Scilit:
- Pandemic Potential of a Strain of Influenza A (H1N1): Early FindingsScience, 2009
- Of Chickens and Men: Avian Influenza in HumansCurrent Molecular Medicine, 2009
- The war against influenza: discovery and development of sialidase inhibitorsNature Reviews Drug Discovery, 2007
- Strategies of Development of Antiviral Agents Directed Against Influenza Virus ReplicationCurrent Pharmaceutical Design, 2007
- Influenza vaccine: The challenge of antigenic driftVaccine, 2007
- Influenza A/H5N1 virus infection in humans in CambodiaJournal of Clinical Virology, 2007
- Antiviral agents active against influenza A virusesNature Reviews Drug Discovery, 2006
- Influenza Pandemics of the 20th CenturyEmerging Infectious Diseases, 2006
- Influenza Vaccine — Outmaneuvering Antigenic Shift and DriftNew England Journal of Medicine, 2004
- Are We Ready for Pandemic Influenza?Science, 2003